GENI Relative Valuation - Genincode PLC

Watchlist Manager

Watchlist

Price: 1.25 GBX -5.66%

Market Cap: £9.4m

G	Genincode PLC LSE:GENI	UK
B	Bayridge Resources Corp OTC:BYRRF	CA
	CD Projekt SA OTC:OTGLF	PL
H	Hod Assaf Industries Ltd TASE:HOD	IL
S	SuperRobotics Holdings Ltd HKEX:8176	HK
	Basler AG LSE:0DUI	DE
	Nanjing Inform Storage Equipment Group Co Ltd SSE:603066	CN
J	Jiangsu Tongxingbao Intelligent Transportation Technology Co Ltd SZSE:301339	CN
T	TTK Healthcare Ltd BSE:507747	IN
	Ubiquitous AI Corp TSE:3858	JP
	Bigbloc Construction Ltd NSE:BIGBLOC	IN
D	Dalian Insulator Group Co Ltd SZSE:002606	CN
	ENC Digital Technology Co Ltd SSE:603869	CN
E	ETS Holdings Co Ltd TSE:1789	JP
S	Sociedad de Inversiones Campos Chilenos SA SGO:CAMPOS	CL
	Hangzhou Honghua Digital Technology Stock Co Ltd SSE:688789	CN
	Nihon Chouzai Co Ltd TSE:3341	JP
	Fingerprint Cards AB STO:FING B	SE
C	Citizens Bancshares Corp (South Carolina) OTC:CZBS	US
	Digital Garage Inc TSE:4819	JP
	Global Mixed Mode Technology Inc TWSE:8081	TW
	NuGene International Inc OTC:NUGN	US
	Artelo Biosciences Inc NASDAQ:ARTL	US

Multiples-Based Value

GENI price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

GENI doesn't have a meaningful market cap.

The Multiples-Based Value for Genincode PLC (GENI) under the Base Case is hidden GBX. Compared with the current market price of 1.25 GBX, the stock appears hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

GENI Multiples-Based Value

Unlock

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
UK	G	Genincode PLC LSE:GENI	9.4m GBP	3.2	-1.9	-1.5	-1.4
US		CVS Health Corp NYSE:CVS	98.7B USD	0.2	53.8	13.8	13.8
US	C	Cigna Group XMUN:CGN	68.1B EUR	0.3	13.1	7.7	9.8
US		Cigna Corp NYSE:CI	71.8B USD	0.3	11.8	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.3B EUR	1.1	19.7	9.9	14.6
DE		Fresenius Medical Care AG XMUN:FME	23.7B EUR	1.2	23.7	9.1	16.8
US		Laboratory Corporation of America Holdings NYSE:LH	22.1B USD	1.6	25.3	12.1	17.6
US		Quest Diagnostics Inc NYSE:DGX	21.4B USD	1.9	21.6	11.8	15.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.1B EUR	0.6	11.1	5.3	9.9
US		Guardant Health Inc NASDAQ:GH	11.3B USD	11.5	-27.1	-29.7	-27
US		DaVita Inc NYSE:DVA	10.2B USD	0.7	13.3	7	9.5

				Revenue Growth	P/S to Growth
UK	G	Genincode PLC LSE:GENI	Average P/S: 2.1 3.2	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	2%	0.6
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	1.9	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	2%	0.3
US		Guardant Health Inc NASDAQ:GH	11.5	29%	0.4
US		DaVita Inc NYSE:DVA	0.7	4%	0.2

				Earnings Growth	PEG
UK	G	Genincode PLC LSE:GENI	Average P/E: 21.5 Negative Multiple: -1.9	N/A	N/A
US		CVS Health Corp NYSE:CVS	53.8	90%	0.6
US	C	Cigna Group XMUN:CGN	13.1	19%	0.7
US		Cigna Corp NYSE:CI	11.8	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.7	25%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.7	15%	1.6
US		Laboratory Corporation of America Holdings NYSE:LH	25.3	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.6	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.1	15%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.1	N/A	N/A
US		DaVita Inc NYSE:DVA	13.3	19%	0.7

				EBITDA Growth	EV/EBITDA to Growth
UK	G	Genincode PLC LSE:GENI	Average EV/EBITDA: 9.6 Negative Multiple: -1.5	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.8	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	5%	1.5
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.9	10%	1
DE		Fresenius Medical Care AG XMUN:FME	9.1	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.1	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.7	N/A	N/A
US		DaVita Inc NYSE:DVA	7	4%	1.8

				EBIT Growth	EV/EBIT to Growth
UK	G	Genincode PLC LSE:GENI	Average EV/EBIT: 13.5 Negative Multiple: -1.4	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.8	22%	0.6
US	C	Cigna Group XMUN:CGN	9.8	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.6	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.8	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.6	18%	1
US		Quest Diagnostics Inc NYSE:DGX	15.8	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.9	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27	N/A	N/A
US		DaVita Inc NYSE:DVA	9.5	5%	1.9

Genincode PLC
LSE:GENI

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

GENI Competitors Multiples
Genincode PLC Competitors

See Also

Company

Help

Tools

Stocks

Genincode PLC LSE:GENI

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

GENI Competitors Multiples Genincode PLC Competitors

See Also

Company

Help

Tools

Stocks

Genincode PLC
LSE:GENI

GENI Competitors Multiples
Genincode PLC Competitors